[A trial of clinical application of sparfloxacin for treating mycobacterial infections].
Sparfloxacin seems to be a good candidate for antimycobacterial treatment. However, there have been no clinical studies. We experienced 2 SPFX-treated cases, who could not use other antimycobacterial agents because of side effect, we tried SPFX-treatment on these cases. Good results were obtained, however, for long time use to prevent side effects, we tried SPFX every second day and monitored the serum levels of SPFX. SPFX-every second day treatment gave good clinical results and adequate serum levels of SPFX were observed.
Yoshikawa
H
H
Shinrakuen Hospital.
Aoki
N
N
Usuda
Y
Y
Wada
K
K
Arakawa
M
M
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D008297:Male; D008875:Middle Aged; D009164:Mycobacterium Infections / Q000188:drug therapy*; D015363:Quinolones / Q000008:administration & dosage*
D024841:Fluoroquinolones; D015363:Quinolones; C061363:sparfloxacin